Hunan Warrant Pharmaceutical Co Ltd banner

Hunan Warrant Pharmaceutical Co Ltd
SSE:688799

Watchlist Manager
Hunan Warrant Pharmaceutical Co Ltd Logo
Hunan Warrant Pharmaceutical Co Ltd
SSE:688799
Watchlist
Price: 55.75 CNY -1.52%
Market Cap: ¥7.3B

Hunan Warrant Pharmaceutical Co Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Hunan Warrant Pharmaceutical Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Hunan Warrant Pharmaceutical Co Ltd
SSE:688799
Operating Income
¥168.7m
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥6.6B
CAGR 3-Years
37%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥9B
CAGR 3-Years
42%
CAGR 5-Years
6%
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥4.8B
CAGR 3-Years
13%
CAGR 5-Years
3%
CAGR 10-Years
4%
Zhejiang Nhu Co Ltd
SZSE:002001
Operating Income
¥7.8B
CAGR 3-Years
22%
CAGR 5-Years
13%
CAGR 10-Years
35%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Operating Income
¥3.7B
CAGR 3-Years
N/A
CAGR 5-Years
203%
CAGR 10-Years
N/A
No Stocks Found

Hunan Warrant Pharmaceutical Co Ltd
Glance View

Market Cap
7.3B CNY
Industry
Pharmaceuticals

Hunan Warrant Pharmaceutical Co., Ltd. engages in the production of Chinese medicine. The company is headquartered in Changsha, Hunan and currently employs 1,103 full-time employees. The company went IPO on 2021-07-13. The firm's products include pharmaceutical preparations, raw materials and intermediates, plant extracts and food. Its products cover areas such as digestion, breathing, and anti-infection. The firm mainly conducts business within the domestic market.

Intrinsic Value
31.87 CNY
Overvaluation 43%
Intrinsic Value
Price ¥55.75

See Also

What is Hunan Warrant Pharmaceutical Co Ltd's Operating Income?
Operating Income
168.7m CNY

Based on the financial report for Dec 31, 2024, Hunan Warrant Pharmaceutical Co Ltd's Operating Income amounts to 168.7m CNY.

What is Hunan Warrant Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
6%

Over the last year, the Operating Income growth was -24%. The average annual Operating Income growth rates for Hunan Warrant Pharmaceutical Co Ltd have been -1% over the past three years , 6% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett